Business Standard

Kilitch Drugs (India) standalone net profit rises 160.87% in the December 2017 quarter

Image

Capital Market

Sales rise 79.75% to Rs 13.05 crore

Net profit of Kilitch Drugs (India) rose 160.87% to Rs 1.80 crore in the quarter ended December 2017 as against Rs 0.69 crore during the previous quarter ended December 2016. Sales rose 79.75% to Rs 13.05 crore in the quarter ended December 2017 as against Rs 7.26 crore during the previous quarter ended December 2016. ParticularsQuarter EndedDec. 2017Dec. 2016% Var.Sales13.057.26 80 OPM %16.7010.88 -PBDT2.230.96 132 PBT1.930.62 211 NP1.800.69 161

Powered by Capital Market - Live News

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 19 2018 | 4:35 PM IST

Explore News